Details for Patent: RE40045
✉ Email this page to a colleague
Summary for Patent: RE40045
Title: | Medicaments |
Abstract: | Pharmaceutical compositions comprising effective amounts of salmeterol (and a physiologically acceptable salt thereof) and fluctuations propionate as a combined preparation for simultaneous, sequential or separate administration by inhalation in the treatment of respiratory disorders. |
Inventor(s): | Palmer; James B. D. (Princeton, NJ) |
Assignee: | Glaxo Group Limited (Greenford, GB) |
Application Number: | 10/933,483 |
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; |
Drugs Protected by US Patent RE40045
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: RE40045
International Family Members for US Patent RE40045
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 0416951 | ⤷ Sign Up | C990012 | Netherlands | ⤷ Sign Up |
European Patent Office | 0416951 | ⤷ Sign Up | 12/1999 | Austria | ⤷ Sign Up |
Austria | 99941 | ⤷ Sign Up | |||
Australia | 6226290 | ⤷ Sign Up | |||
Australia | 640682 | ⤷ Sign Up | |||
Belgium | 1003053 | ⤷ Sign Up | |||
Canada | 2024916 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |